跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
LIDOCAINE 2% AND EPINEPHRINE 1:100,000
Authorized
STANDARD
LIDOCAINE 2% AND EPINEPHRINE 1:100,000
Septodont
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b0007de8f85439aa
Company
Septodont
Type
Standard
Approval Details
Approval Id
b0007de8f85439aa
Drug Approval Canada Name
LIDOCAINE 2% AND EPINEPHRINE 1:100,000
Product Name
LIDOCAINE 2% AND EPINEPHRINE 1:100,000
Status
Marketed
Status Date
2019-04-29
Original Market Date
2019-04-29
Din
02473518
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Block/Infiltration
Schedule
Ethical
Ahfs
72:00.00
Atc Original
N01BB52 LIDOCAINE, COMBINATIONS
Atc Name
n 01 bb 52
Aig Number
0201284005
Company Name
Septodont
Company Address
58 Rue Du Pont De Creteil, St-Maur-Des-Fosses, Val-De-Marne, France, 94107
Company Detail Path
/organization/septodont
Company Information
Pharmaceutical Company Name
Septodont
Country Name
Belgium
Website
http://www.lamaire.be
Active Ingredients
LIDOCAINE HYDROCHLORIDE
20 MG / ML
EPINEPHRINE (EPINEPHRINE BITARTRATE)
0.01 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b0007de8f85439aa
Type
Standard
Back to Health Canada Approvals
LIDOCAINE 2% AND EPINEPHRINE 1:100,000 - Health Canada Drug Approval Details